1-18 of 18
Kristen McCullough
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Zhuoer Xie, Jenna Fernandez, Terra L Lasho, Christy M. Finke, Michelle Amundson, Kristen McCullough, Betsy LaPlant, Abhishek A Mangaonkar, Naseema Gangat, Kaaren K Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik
Journal: Blood
Blood blood.2024024962.
https://doi.org/10.1182/blood.2024024962
Published: 2024
Includes: Supplemental data
Journal Articles

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias

Zhuoer Xie, Kristen McCullough, Terra L Lasho, Jenna A. Fernandez, Christy M Finke, Michelle Renee Amundson, Betsy LaPlant, Abhishek Mangaokar, Naseema Gangat, Kaaren K. Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik
Journal: Blood
Blood (2023) 142 (Supplement 1): 4611.
https://doi.org/10.1182/blood-2023-186595
Published: 2023
Journal Articles

Venetoclax + Cladribine + Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax + Hypomethylating Agent

Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2853.
https://doi.org/10.1182/blood-2023-185185
Published: 2023
Journal Articles

Survival and Prognosis Among 301 Patients with Newly-Diagnosed Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy

Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla Johnson, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 591.
https://doi.org/10.1182/blood-2023-178837
Published: 2023
Journal Articles

ELN 2022 Favorable Genetic Risk Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agent: Predictors of Response and Survival

Kristen McCullough, Omer Karrar, Moazah Iftikhar, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 5925.
https://doi.org/10.1182/blood-2023-182326
Published: 2023
Journal Articles

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias of Undetermined Significance

Zhuoer Xie, Kristen McCullough, Terra Lasho, Jenna A. Fernandez, Christy Finke, Michelle Renee Amundson, Betsy Laplant, Abhishek A. Mangaonkar, Naseema Gangat, Kaaren K. Reichard, Michelle A Elliott, Thomas E. Witzig, Mrinal M.M. Patnaik
Journal: Blood
Blood (2022) 140 (Supplement 1): 2893–2894.
https://doi.org/10.1182/blood-2022-165163
Published: 2022
Journal Articles

U2AF1 Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with BCOR Mutations

Stephanie L. Pritzl, Talha Badar, Alejandro Ferrer, Terra Lasho, Christy Finke, Abhishek A. Mangaonkar, Kristen McCullough, Naseema Gangat, Jenna A. Fernandez, Aref Al-Kali, David S. Viswanatha, Rong He, James M. Foran, Mrinal M. Patnaik
Journal: Blood
Blood (2022) 140 (Supplement 1): 11408–11409.
https://doi.org/10.1182/blood-2022-166794
Published: 2022
Journal Articles

Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy

Isla McKerrow Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3233–3234.
https://doi.org/10.1182/blood-2022-167967
Published: 2022
Journal Articles

Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy

Rimal Ilyas, Isla McKerrow Johnson, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Mrinal M.M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2022) 140 (Supplement 1): 1286–1287.
https://doi.org/10.1182/blood-2022-165491
Published: 2022
Journal Articles

Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm

Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M.M. Patnaik, Mark R. Litzow, William J. Hogan, Abhishek A. Mangaonkar, Hassan B. Alkhateeb, Mithun V. Shah, Michelle A Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9675–9676.
https://doi.org/10.1182/blood-2022-163485
Published: 2022
Journal Articles

CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients

Rimal Ilyas, Kristen McCullough, Talha Badar, Mrinal M.M. Patnaik, Hassan B. Alkhateeb, Abhishek A. Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2022) 140 (Supplement 1): 9704–9705.
https://doi.org/10.1182/blood-2022-160222
Published: 2022
Journal Articles

Therapy-Related Cytopenia of Undetermined Significance (t-CCUS) As a Precursor to Therapy-Related Myeloid Neoplasms (t-MN)

Mithun V. Shah, Abhishek A. Mangaonkar, Kebede H. Begna, Hassan B. Alkhateeb, Patricia Greipp, Dong Chen, David S. Viswanatha, Rong He, Michelle A Elliott, William J Hogan, Mark R. Litzow, Kristen McCullough, Ayalew Tefferi, Naseema Gangat, Mrinal M. Patnaik, Aref Al-Kali
Journal: Blood
Blood (2021) 138 (Supplement 1): 1096.
https://doi.org/10.1182/blood-2021-145696
Published: 2021
Journal Articles

Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents

Isla M. Johnson, Evandro D. Bezerra, Faiqa Farrukh, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Mark R. Litzow, William J Hogan, Mithun V. Shah, Mrinal M. Patnaik, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2021) 138 (Supplement 1): 219.
https://doi.org/10.1182/blood-2021-149704
Published: 2021
Journal Articles

IDH2 Inhibitor Therapy in Relapsed and Refractory Acute Myeloid Leukemia: A Single Institution Experience

Marissa Li, MD, Erika Morsia, MD, Christopher E. Wee, MD, Kristen McCullough, PharmD, Aref Al-Kali, MD, William J Hogan, MB, BCh, Mrinal M. Patnaik, MDMBBS, Ayalew Tefferi, MD, Naseema Gangat, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-137505
Published: 2020
Journal Articles

Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes

Heather Personett May, PharmD, Erin F Barreto, PharmD, Kristin C. Mara, MS., Kristen McCullough, PharmD, Nelson Leung, MD, Thomas M. Habermann, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1628.
https://doi.org/10.1182/blood-2019-131149
Published: 2019
Journal Articles

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Darci Zblewski, APRN, C-NP, Naseema Gangat, MBBS, Michelle A. Elliott, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, C. Christopher Hook, MD, Tyler Mielke, Alexandra Wolanskyj, MD, Willam Hogan, MB, BCh, Animesh Pardanani, MBBS, PhD, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Lindsey Ann Kluck, MSN, NP, Adrienne Nedved, Pharm.D., R,Ph, Kristen McCullough, PharmD, Matthew Smith, Pharm.D., R.Ph, Tammy McAllister, M.A., Konstantinos Lazaridis, MD, A Keith Stewart, MB, ChB, Mrinal M. Patnaik, MD MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5440.
https://doi.org/10.1182/blood-2018-99-118600
Published: 2018
Journal Articles

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Thomas M. Habermann, MD, Ruth A Lentz, R.N., John J Schmitz, MD, Alexander G von Bormann, BA, Jason Young, MD, Christopher H Hunt, MD, Grzegorz S. Nowakowski, MD, Kristen McCullough, PharmD, Pedro Horna, MD, Adam J Wood, MD, William R. Macon, MD, Paul J Kurtin, MD, Scott L Stafford, MD, Usha Sree Chamarthy, MD, Faraz Khan, MD, Stephen M. Ansell, MD PhD, Rebecca L King, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2247.
https://doi.org/10.1182/blood-2018-99-112887
Published: 2018
Journal Articles

Impact of Early Rasburicase on Incidence and Outcomes of Clinical Tumor Lysis Syndrome in Lymphoma

Heather A Personett, PharmD, Erin F Barreto, PharmD, Kristen McCullough, PharmD, Ross Dierkhising, MS, Nelson Leung, MD, Thomas M. Habermann, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1717.
https://doi.org/10.1182/blood-2018-99-115042
Published: 2018